26 Broadway, 14 Floor, 14 Floor
16 articles with JDRF
150 Youth with Type 1 Diabetes Selected to Participate in 2019 JDRF Children's Congress in Washington, D.C.
JDRF, the leading global organization funding type 1 diabetes research, announced the selection of more than 150 youth delegates who will be traveling to Washington, D.C. for the JDRF 2019 Children's Congress from July 8-10.
Sports and Entertainment Stars Converge on Capitol Hill to Advocate for Research Funding and Policies that Support the Type 1 Diabetes Community
Celebrities join more than 160 youth Delegates at JDRF 2019 Children's Congress to meet with Congress
Immunotherapy delays diagnosis in people at high risk
5/30/2019About 1% of patients treated for cancer with checkpoint inhibitors can develop an autoimmune disease similar to Type 1 diabetes.
4/12/2019Biopharma companies tap new hires to assume roles in leadership positions, with additions at Metrion, JDRF, Ribometrix, and more.
JDRF Board Appoints Leading Diabetes Researcher and Advocate Aaron J. Kowalski, Ph.D. as New President & CEO
Internationally recognized diabetes expert, first JDRF CEO with T1D will lead next phase of focused effort to end type 1 diabetes
JDRF announced today that it made progressive advances this year on its path to a cure, funding new therapeutic developments to better treat the chronic autoimmune disease affecting 1.25 million Americans.
JDRF is commemorating National Diabetes Awareness Month (NDAM) this November by raising awareness of T1D and the urgent need to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications.
JDRF names internationally renowned cellist as a global ambassador
Watertown, Massachusetts-based SQZ Biotechnologies completed an oversubscribed Series C financing worth $72 million. New investors included Everblue, Illumina Ventures, Invus, Orient Life, and Viva Ventures Biotech Group.
SFC Fluidics, Inc. Announces Partnership with JDRF to Develop Patch Pump with Open-Protocol Communication
SFC Fluidics, Inc. announced a new Industry Discovery and Development Partnership supported by JDRF, the leading global organization funding type 1 diabetes (T1D) research.
JDRF Awards International Diabetes Center Grant to Investigate the Use of Intranasal Insulin Delivery
JDRF announces the awarding of a research grant to International Diabetes Center (IDC) in Minneapolis.
Programme aims to advance knowledge in type 1 diabetes with support for research projects over three years.
This funding commitment from JDRF will enable Cam Med to further the development of its innovative Evopump, an ultra-thin and flexible, bandage-like patch pump.
JDRF Partners with EOFlow to Develop Wearable Automated Insulin Delivery System for People With Type 1 Diabetes
The product incorporates a proprietary electroosmotic pumping technology which allows it to be smaller and lighter.
SFC Fluidics, Inc. Announces Partnership with JDRF to Develop Pod Device for Automated Insulin Delivery
SFC Fluidics, Inc. (SFC), a medical technology company, today announced a new Industry Development and Discovery Partnership supported by JDRF, the leading global organization funding type 1 diabetes (T1D) research.